The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Urges Caution with Steroid Injections for Hip Osteoarthritis

Study Urges Caution with Steroid Injections for Hip Osteoarthritis

April 26, 2018 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Based on the two radiologists’ reports, the study found that 22–24% of patients with hip OA who received steroid injections showed new osteonecrosis compared with 9% of patients in the hip control group and 5% in the control group of patients who received shoulder steroid injections.3

You Might Also Like
  • Effectiveness of Steroid Injections vs. Placebo Evaluated for Knee Pain
  • Steroid Injections for Lateral Epicondylalgia Worse than Placebo in Long Term
  • Use Epidural Steroid Injections Cautiously in Patients with Fracture Risk
Explore This Issue
April 2018
Also By This Author
  • Study Finds Renal Arteriosclerosis Is Common in Lupus Nephritis Patients

In specific, the radiologists found bone collapse in the head of the femur bone in 15–17% of the patients in the intervention group compared with 4% in the hip control group and 2% in the control group of patients who received shoulder steroid injections.3

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Commenting in a press release, Dr. Chang noted the rapid changes in bone in the intervention group. “Changes due to osteoarthritis, such as narrowing in the space between joints and the developments of bony proliferations, typically develop slowly over time. When reading follow-up radiographs of patients who had received a hip injection, we noticed changes had developed rapidly in some patients.”4

Caution Warranted: More Data Needed

Saying the study provides note­worthy observations about the potential effects of steroid injections in the hip, Sharon L. Kolasinski, MD, pro­fessor of clinical medicine, Division of Rheumatology, Penn Musculoskeletal Center, Perelman School of Medicine, University of Pennsylvania, emphasizes that more information is needed to understand which patients may be at risk for the deleterious effects noted in the study.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We need to know exactly who the population is that is at risk and how big that risk is,” she says.

Dr. Kolasinski

Dr. Kolasinski

Dr. Kolasinski emphasizes that the study offers an important observation that has not been made in previous studies. “There hasn’t been a previous study that looked at radiographic change following hip injection,” she says. “If you don’t look for it, you may miss it.”

Of note, she says, were the rapid changes to bone in the hip patients who received the injections. “It is really eye [opening] to see the percentages of patients with radiographic progression over a relatively short period of time following these injections,” she says. “Further, the percentage of patients experiencing osteonecrosis or new collapse is quite remarkable.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In her comments in the press release, Dr. Chang noted that the patients with hip OA who received the steroid injections had disease that was severe enough to warrant the injections and therefore, compared with the control groups, were prone to faster progression of bony changes.

“We need to look at what’s going on with the steroid/anesthetic injectate and osteoarthritis patients to determine what’s causing the changes that occur in some patients,” she says in the press release.4

Pages: 1 2 3 | Single Page

Filed Under: Osteoarthritis Tagged With: hip, steroid injectionIssue: April 2018

You Might Also Like:
  • Effectiveness of Steroid Injections vs. Placebo Evaluated for Knee Pain
  • Steroid Injections for Lateral Epicondylalgia Worse than Placebo in Long Term
  • Use Epidural Steroid Injections Cautiously in Patients with Fracture Risk
  • Letters: A Word of Caution on Colchicine Study

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.